Skip to content
V1911-16 ·3 May 2016 ·consulta-vinculante Medium impact
Tax

Hyaluronic acid gel subject to 10% VAT if it meets pharmaceutical product requirements for direct use

A query was made regarding the applicable tax rate for a hyaluronic acid gel used to prevent post-surgical adhesions. The DGT indicates that the reduced rate of 10% may apply if the product meets specific Combined Nomenclature requirements and is suitable for direct use by the end consumer.

In 6 key points

How it affects those involved

This ruling clarifies the VAT treatment for specific medical gels, potentially reducing the tax burden for products that qualify as pharmaceutical goods for direct consumer use.

Lifecycle

2016-05-03PublishedPublished in the BOE
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The tax team reviews your specific situation.

Talk to the tax team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact